Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

Moving misbranded and adulterated HIV drugs from the black market to retail pharmacies and HIV patients was a $60 million ...

has led to near-normal life expectancies for people living with HIV (PLHIV), shifting the leading cause of death (COD) from AIDS-related to non-AIDS-related mortality. We assessed trends in COD among ...

A former top federal health official who served during President Trump’s first term warned that the drastic cuts to the ...

The trial is testing a new easy-to-administer and patient-friendly sustained-release formulation of flucytosine, a key ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in ...

In the early 1980s, the virus’s ravages were treated as “something that happens over there, only to those people,” Juan Michael Porter II, a health journalist and an HIV activist, told me. But the ...

Women may experience unique symptoms of HIV. Early on, human immunodeficiency virus (HIV ... progress to acquired immunodeficiency syndrome (AIDS), which increases the risk of severe infections.

SAN FRANCISCO — The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, a population at greater risk for acquiring HIV ...